Past event: Cell and Gene Therapy 2023 Conference

Driving the potential of gene-based medicine through cutting-edge technologies to target undruggable diseases

We are proud to announce the Cell and Gene Therapy Conference taking place on the 19th - 20th June 2023.

As part of our leading series of drug discovery conferences, this year's event will bring together expertise from individuals across the advanced therapeutics community. The two-day conference will offer a series of presentations, through which you will gain insight into the latest developments in discovery, development and delivery of cell and gene therapies.

Largely owing to the success and regulatory approvals of mRNA vaccines in recent years, there has been a renewed spotlight on cell and gene therapies and this "second-wave" is proving highly successful in accelerating R&D in the space through increased investment. This year's conference will consider the latest approaches to therapeutic discovery and the impact of technologies such as AI and CRISPR/CAS-9. Novel approaches to delivery and screening have also taken hold and case studies on applications in oncology and rare diseases will demonstrate the enormous potential of cell and gene therapies for new and effective opportunities in personalised medicine.

This event will not only bring you the key insights you need to develop your cell and gene therapy pipeline by benchmarking against the latest case studies, but it will also give you the opportunity to network with key players throughout the industry.

We hope to welcome you to this must attend event in June 2023.

Benefits of Attending

  • EXPLORE the approaches being undertaken to develop cancer and rare disease treatments now to expand your future cell and gene therapy portfolio, with the potential for personalised cancer vaccines, stem-cell treatments for heart failure and haemophilia gene therapies
  • DISCOVER the latest industry developments in the cell and gene therapy field to expand your target range with updates and innovations in: direct CNS-delivery, off-the-shelf screening libraries and personalised neoantigen therapeutics
  • UNCOVER how CRISPR/cas9 has laid the foundation for the next-generation of gene-editing technologies and how challenges in safety, delivery and efficacy have been overcome with real-world-examples from AstraZeneca, CRISPR Therapeutics and Bayer
  • REVIEW approval case studies from a line-up of global industry experts from Astellas, Adaptimmune, Oxford Biomedica and the MHRA to better understand the regulatory pathways.

Who should attend

International pharmaceutical experts:
  • Cell & Gene Therapy R&D leaders
  • Clinical Platform Developers
  • Technical experts
  • Advanced therapy production
Industry:
  • Businesses looking to break into the market
  • Established players looking to expand their contacts
  • Developers and innovators in cell and gene therapy technology

Speakers

  • Chrysanthi Sitmalidou, Scientist II, Orchard Therapetuics
  • Clare Jones, Chief Scientific Officer, Talisman Therapeutics
  • Diego Ardigo, ATMP Project and Clinical Program Leader, Chiesi Farmaceutici SpA
  • Giulia Leoni, Associate Director, Program Management and LeadershipAssociate, Bloomsbury Genetic Therapies
  • Giuseppe Ronzitti, Group Leader, Genethon
  • John Maher, Chief Scientific Officer, Leucid Bio
  • Katie Binley, Head of Biology, Ikarovec
  • Lior Raviv, CTO, Pluristem
  • Nagy Habib, Co-Founder and CMO , Dawn Therapeutics
  • Ningshu Liu, Head of Stem Cells, FosunPharma
  • Pelin Candarlioglu, Cell Biologist/Bioengineer - Complex in Vitro Models, GlaxoSmithKline
  • Roberto Nitsch, Director - Gene Therapy, Astrazeneca
  • Sergio Quezada, Chief Scientific Officer, Achilles Therapeutics
  • Takehiko Kaneko, CMO, HeartSeed
  • Thomas Lowe, Clinical Development Scientist, AviadoBio
  • William Finch, CEO, Oxford Vacmedix

Please fill in your name and email to receive the Conference Agenda of this event.

Venue

Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK


To book your hotel room with our preferential group rate for our Cell and Gene Therapy conference please visit the hotel website Copthorne Tara Hotel London Kensington and enter the code SMIC180623 into the promo box found on the right hand side of the page.

Please note that the preferential group rate for this event is only applicable to Superior Rooms, and therefore, this code will not work for other room types.

If you require an alternative room and further assistance, please contact Groups Tara
groups.tara@millenniumhotels.com.

The promo code and above link can only be used up to 30 days prior to the start of the conference (Friday 19th May 2023). For bookings post Friday 19th May 2023 the preferential group rate cannot be guaranteed, and rooms are subject to availability.
Event details
Organizer : SAE Media Group
Event type : Conference
Reference : ASDE-24104